Tumor promotion by FOXO3 has been discussed for several years.17, 19, 43, 44, 45, 46 Here, we identified a subtype of NB cells, where FOXO3-activation protected the cancer cells against DNA-damaging chemotherapeutic agents. The gene discussed is FOXO3; the disease is cancer.